Mulmit

Senti Biosciences Holdings, Inc.Senti Biosciences Holdings, Inc.

SNTI Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-3122,000-68,779,000-61,438,000-2.73
2024-12-310-61,039,000-52,790,000-12.03
2023-12-311,978,000-92,727,000-71,058,000-16.01
2022-12-313,286,000-62,084,000-58,210,000-2.23
2021-12-312,291,000-40,446,000-55,319,000-19

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-03-09Rajangam KanyaPres. & Chief Med. & Dev. Off.10,757
2026-03-09Lu Timothy KCEO80,666
2026-02-02Rajangam KanyaPres. & Chief Med. & Dev. Off.1,384
2026-02-02Lu Timothy KCEO4,191
2025-07-18Baum Bryan Daniel43,900
2025-06-25Collins James J.21,950
2025-06-25Hsiung Feng21,950
2025-06-25Schulz Fran21,950
2025-06-25COOPERSTONE BRENDA21,950
2025-06-25Tang Donald F21,950
2025-06-25Mathers Edward T21,950
2025-03-10Celadon Partners SPV 249,777,000

8-K events

FiledItems
2026-09-04Entry into a material agreement · Creation of a direct financial obligation · Financial statements and exhibits
2026-09-02Entry into a material agreement · Delisting or listing-standard notice
2026-08-20Entry into a material agreement · Creation of a direct financial obligation
2026-07-15Entry into a material agreement · Results of operations · Change in control · Regulation FD disclosure · Other events · Financial statements and exhibits
2026-05-26Entry into a material agreement · Creation of a direct financial obligation · Financial statements and exhibits
2026-05-14Results of operations · Other events · Financial statements and exhibits
2026-05-01Entry into a material agreement · Creation of a direct financial obligation · Unregistered sales of equity securities · Change in control · Financial statements and exhibits
2026-04-01Other events
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Biological Products, (No Diagnostic Substances) — 같은 업종, 그리고 규모가 비슷한 기업Biological Products, (No Diagnostic Substances) — and other companies of a similar size

SEC가 같은 업종(Biological Products, (No Diagnostic Substances))으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Biological Products, (No Diagnostic Substances)) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.